These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 17020756

  • 1. Asymmetric dimethylarginine (ADMA) and hyperhomocysteinemia in patients with acute myocardial infarction.
    Korandji C, Zeller M, Guilland JC, Vergely C, Sicard P, Duvillard L, Gambert P, Moreau D, Cottin Y, Rochette L.
    Clin Biochem; 2007 Jan; 40(1-2):66-72. PubMed ID: 17020756
    [Abstract] [Full Text] [Related]

  • 2. Endothelial dysfunction in patients with peripheral arterial disease and chronic hyperhomocysteinemia: potential role of ADMA.
    Sydow K, Hornig B, Arakawa N, Bode-Böger SM, Tsikas D, Münzel T, Böger RH.
    Vasc Med; 2004 May; 9(2):93-101. PubMed ID: 15521698
    [Abstract] [Full Text] [Related]

  • 3. Plasma asymmetric and symmetric dimethylarginine in a rat model of endothelial dysfunction induced by acute hyperhomocysteinemia.
    Magné J, Huneau JF, Borderie D, Mathé V, Bos C, Mariotti F.
    Amino Acids; 2015 Sep; 47(9):1975-82. PubMed ID: 25792109
    [Abstract] [Full Text] [Related]

  • 4. Asymmetric dimethylarginine is associated with macrovascular disease and total homocysteine in patients with type 2 diabetes.
    Krzyzanowska K, Mittermayer F, Krugluger W, Schnack C, Hofer M, Wolzt M, Schernthaner G.
    Atherosclerosis; 2006 Nov; 189(1):236-40. PubMed ID: 16414052
    [Abstract] [Full Text] [Related]

  • 5. Relations between plasma asymmetric dimethylarginine (ADMA) and risk factors for coronary disease.
    Wang J, Sim AS, Wang XL, Salonikas C, Naidoo D, Wilcken DE.
    Atherosclerosis; 2006 Feb; 184(2):383-8. PubMed ID: 15939423
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of asymmetric dimethylarginine and homocysteine in microangiopathy-related cerebral damage.
    Notsu Y, Nabika T, Bokura H, Suyama Y, Kobayashi S, Yamaguchi S, Masuda J.
    Am J Hypertens; 2009 Mar; 22(3):257-62. PubMed ID: 19057516
    [Abstract] [Full Text] [Related]

  • 7. Increased Symmetric Dimethylarginine Level Is Associated with Worse Hospital Outcomes through Altered Left Ventricular Ejection Fraction in Patients with Acute Myocardial Infarction.
    Lorin J, Guilland JC, Stamboul K, Guenancia C, Cottin Y, Rochette L, Vergely C, Zeller M.
    PLoS One; 2017 Mar; 12(1):e0169979. PubMed ID: 28125604
    [Abstract] [Full Text] [Related]

  • 8. Asymmetric dimethylarginine in adults with cystathionine β-synthase deficiency.
    Rocha MS, Teerlink T, Janssen MC, Kluijtmans LA, Smulders Y, Jakobs C, Tavares de Almeida I, Rivera I, Castro R, Blom HJ.
    Atherosclerosis; 2012 Jun; 222(2):509-11. PubMed ID: 22484094
    [Abstract] [Full Text] [Related]

  • 9. Association of homocysteine and asymmetric dimethylarginine with atherosclerosis and cardiovascular events in maintenance hemodialysis patients.
    Kumagai H, Sakurai M, Takita T, Maruyama Y, Uno S, Ikegaya N, Kato A, Hishida A.
    Am J Kidney Dis; 2006 Nov; 48(5):797-805. PubMed ID: 17059999
    [Abstract] [Full Text] [Related]

  • 10. Asymmetric dimethylarginine is not elevated in exfoliation syndrome but symmetric dimethylarginine is related to exfoliative glaucoma.
    Blomster H, Puustjärvi T, Kontkanen M, Valtonen P, Teräsvirta M, Uusitalo H.
    Graefes Arch Clin Exp Ophthalmol; 2007 Feb; 245(2):204-9. PubMed ID: 17024436
    [Abstract] [Full Text] [Related]

  • 11. Serum homocysteine, asymmetric dimethyl arginine (ADMA) and other arginine-NO pathway metabolite levels in patients with psoriasis.
    Bilgiç Ö, Altınyazar HC, Baran H, Ünlü A.
    Arch Dermatol Res; 2015 Jul; 307(5):439-44. PubMed ID: 25708188
    [Abstract] [Full Text] [Related]

  • 12. Effects of combined supplementation with B vitamins and antioxidants on plasma levels of asymmetric dimethylarginine (ADMA) in subjects with elevated risk for cardiovascular disease.
    Schmitt B, Wolters M, Kressel G, Hülsmann O, Ströhle A, Kühn-Velten WN, Lichtinghagen R, Bub A, Barth SW, Stichtenoth DO, Hahn A.
    Atherosclerosis; 2007 Jul; 193(1):168-76. PubMed ID: 16876171
    [Abstract] [Full Text] [Related]

  • 13. Impact of asymmetric dimethylarginine on mortality after acute myocardial infarction.
    Zeller M, Korandji C, Guilland JC, Sicard P, Vergely C, Lorgis L, Beer JC, Duvillard L, Lagrost AC, Moreau D, Gambert P, Cottin Y, Rochette L.
    Arterioscler Thromb Vasc Biol; 2008 May; 28(5):954-60. PubMed ID: 18276906
    [Abstract] [Full Text] [Related]

  • 14. High levels of asymmetric dimethylarginine are strongly associated with low HDL in patients with acute myocardial infarction.
    Lorin J, Guilland JC, Korandji C, Touzery C, Bichat F, Chagnon A, Cottin Y, Rochette L, Vergely C, Zeller M.
    PLoS One; 2013 May; 8(6):e64796. PubMed ID: 23755144
    [Abstract] [Full Text] [Related]

  • 15. Reduced renal plasma clearance does not explain increased plasma asymmetric dimethylarginine in hypertensive subjects with mild to moderate renal insufficiency.
    Ronden RA, Houben AJ, Teerlink T, Bakker JA, Bierau J, Stehouwer CD, De Leeuw PW, Kroon AA.
    Am J Physiol Renal Physiol; 2012 Jul 01; 303(1):F149-56. PubMed ID: 22552932
    [Abstract] [Full Text] [Related]

  • 16. Symmetric dimethylarginine predicts all-cause mortality following ischemic stroke.
    Schulze F, Carter AM, Schwedhelm E, Ajjan R, Maas R, von Holten RA, Atzler D, Grant PJ, Böger RH.
    Atherosclerosis; 2010 Feb 01; 208(2):518-23. PubMed ID: 19700158
    [Abstract] [Full Text] [Related]

  • 17. Symmetric and asymmetric dimethylarginine as risk markers of cardiovascular disease, all-cause mortality and deterioration in kidney function in persons with type 2 diabetes and microalbuminuria.
    Zobel EH, von Scholten BJ, Reinhard H, Persson F, Teerlink T, Hansen TW, Parving HH, Jacobsen PK, Rossing P.
    Cardiovasc Diabetol; 2017 Jul 11; 16(1):88. PubMed ID: 28697799
    [Abstract] [Full Text] [Related]

  • 18. Increased plasma levels of total homocysteine but not asymmetric dimethylarginine in Hispanic subjects with ischemic stroke FREC-VI sub-study.
    Rueda-Clausen CF, Córdoba-Porras A, Bedoya G, Silva FA, Zarruk JG, López-Jaramillo P, Villa LA.
    Eur J Neurol; 2012 Mar 11; 19(3):417-25. PubMed ID: 21978129
    [Abstract] [Full Text] [Related]

  • 19. Asymmetrical (ADMA) and symmetrical dimethylarginine (SDMA) as potential risk factors for cardiovascular and renal outcome in chronic kidney disease - possible candidates for paradoxical epidemiology?
    Busch M, Fleck C, Wolf G, Stein G.
    Amino Acids; 2006 May 11; 30(3):225-32. PubMed ID: 16680555
    [Abstract] [Full Text] [Related]

  • 20. Plasma concentrations of asymmetric dimethylarginine, nitric oxide and homocysteine in patients with slow coronary flow.
    Yucel H, Ozaydin M, Dogan A, Erdogan D, Turker Y, Ceyhan BM, Sutcu R.
    Scand J Clin Lab Invest; 2012 Oct 11; 72(6):495-500. PubMed ID: 22950626
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.